Circular RNAs (circRNAs), formed by non-sequential back-splicing of pre-mRNA transcripts, are a widespread form of non-coding RNA in animal cells. However, it is unclear whether the majority of circRNAs represent splicing by-products without function or are produced in a regulated manner to carry out specific cellular functions. We show that hundreds of circRNAs are regulated during human epithelialmesenchymal transition (EMT) and find that the production of over one-third of abundant circRNAs is dynamically regulated by the alternative splicing factor, Quaking (QKI), which itself is regulated during EMT. Furthermore, by modulating QKI levels, we show the effect on circRNA abundance is dependent on intronic QKI binding motifs. Critically, the addition of QKI motifs is sufficient to induce de novo circRNA formation from transcripts that are normally linearly spliced. These findings demonstrate circRNAs are both purposefully synthesized and regulated by celltype specific mechanisms, suggesting they play specific biological roles in EMT.
INTRODUCTION
Circular RNAs (circRNAs) were identified in the early 1990s as transcripts with scrambled exon order (Nigro et al., 1991) and continued to be reported for a number of transcripts over the following two decades (Capel et al., 1993; Cocquerelle et al., 1993; Gualandi et al., 2003; Suzuki et al., 2006; Zaphiropoulos, 1997) . However, the advent of next generation sequencing has illuminated circRNAs as an entire class of abundant, non-coding RNAs ubiquitous among eukaryotes (Guo et al., 2014; Jeck and Sharpless, 2014; Jeck et al., 2013; Lasda and Parker, 2014; Memczak et al., 2013; Salzman et al., 2012 Salzman et al., , 2013 Wang et al., 2014a; Wilusz and Sharp, 2013; Zhang et al., 2014) . circRNAs result from a non-canonical form of alternative splicing, most commonly where the splice donor site of one exon is ligated to the splice acceptor site of an upstream exon (Figure 1 ). Lacking 3 0 termini, circRNAs are non-polyadenylated and resistant to digestion of the RNA with RNase R, a highly processive 3 0 exonuclease that non-specifically degrades linear RNA, but not circRNAs, attributes which are exploited in their sequencing and identification (Jeck and Sharpless, 2014) .
The finding that circRNAs are widespread in human and animal tissues raises two important questions: what controls their formation, and what are their function(s) (if any)? Because only two specific circRNAs, cIRS-7/CDR1as and Sry, have had any function ascribed to date, both acting as micro (mi)RNA sponges (Hansen et al., 2013; Memczak et al., 2013) , it remains possible that the majority of circRNAs are accidental by-products of mis-splicing. However, mining of ENCODE sequence data has revealed that patterns of circRNA expression can be cell-type specific, suggesting their formation may be regulated, which in turn would indicate they have functions (Salzman et al., 2013) . Recent reports indicate circRNA formation can be aided by the close proximity of circRNA splice sites mediated by complementary base pairing of inverted repeats in the introns flanking the circRNA-forming exons and that many circRNAs rely on this for their biogenesis (Ashwal-Fluss et al., 2014; Liang and Wilusz, 2014; Zhang et al., 2014) . However, this intron-pairing phenomenon alone cannot explain how a single abundant transcript common to a multitude of cells can host cell-type specific circRNAs (Jeck and Sharpless, 2014; Salzman et al., 2013) . On the other hand, regulated alternative splicing plays a major role in expanding the transcriptome is critical in development and in physiological responses (Kalsotra and Cooper, 2011) , making it likely that splicing factors may participate in regulating circRNA biogenesis. Indeed, production of a single circRNA from the pre-mRNA of the Muscleblind splicing factor was recently shown to be regulated by Muscleblind itself (Ashwal-Fluss et al., 2014) . However, it is not known whether Muscleblind or other factors can regulate circRNAs on a wider scale.
Quaking, which belongs to the STAR family of KH domaincontaining RNA binding proteins, has been found to affect premRNA splicing (Hall et al., 2013; Wu et al., 2002) , mRNA turnover (Larocque et al., 2005) , and translation (Saccomanno et al., 1999) and has been implicated in diseases including ataxia, schizophrenia, and glioblastoma (Ché nard and Stephane, 2008) . The Quaking (QKI) gene is processed into three major isoforms of 5, 6, and 7 Kb, respectively , that have substantially different 3 0 UTRs, but differ by only about 30 amino acids in their C-termini and all of which retain the KH RNA binding domain. QKI 5, the most abundant isoform, is predominantly nuclear, while QKI-6 can be nuclear and cytoplasmic, and QKI-7 is predominantly cytoplasmic (Pilotte et al., 2001) . QKI dimerizes through its N-terminal Qua1 domain (Teplova et al., 2013) and binds bipartite sequence motifs that can be on the same or separate RNA molecules (Teplova et al., 2013) . PAR-CLIP crosslinking analysis in human embryonic kidney cells (HEK293T) indicates the majority of QKI binding occurs within introns, consistent with a role in splicing (Hafner et al., 2010) .
Epithelial-mesenchymal transition (EMT) is a cellular differentiation process important in embryo development, wound healing, and in cancer metastasis (Nieto, 2013) . The differentiation of an epithelial cell into a mesenchymal cell involves drastic changes in cell morphology, in gene expression patterns, and in arrangement and function of the actin cytoskeleton (Bracken et al., 2014) . EMT can be triggered by various ligand-receptor interactions, including TGF-b, Wnt, and FGF, and involves extensive regulatory networks that are controlled by transcription factors and miRNAs (Lamouille et al., 2014) . Because many cancers arise from epithelial cells and need to undergo EMT to become invasive and to metastasise, understanding the regulatory processes involved in EMT may reveal new modalities for therapeutic intervention in cancer progression.
We report here that the expression of hundreds of circRNAs is regulated during EMT in response to TGF-b, with the majority of regulated circRNAs increasing in abundance. To screen for RNA binding proteins that regulate circRNA formation, we devised a dual color reporter construct, called circScreen, allowing simultaneous quantification of linear and circRNA splicing. Using Tables S1 and S2. circScreen, we identified the RNA binding protein Quaking (QKI) as a major regulator of circRNA biogenesis in EMT. Furthermore, we show that introduction of consensus binding sequences for QKI into the flanking introns is sufficient to cause circRNAs to be produced from exons that normally only undergo canonical linear splicing. Because some of the most highly expressed circRNAs are among those that are regulated in EMT, our findings strongly suggest that certain circRNAs have EMT-related functions and thus may affect mesenchymal cell properties such as migration, invasion, and the propensity for cancers to metastasise.
RESULTS
circRNA Formation in EMT To assess whether circRNA production is regulated in EMT, we harvested RNA from immortalized human mammary epithelial (HMLE) cells before and after they had undergone EMT in response to treatment with TGF-b. The TGF-b-treated cells are stably mesenchymal with typical morphology and marker expression and are referred to as mesHMLE cells ( Figure 1B ) (Attema et al., 2013; Mani et al., 2008) . RNA from two biological replicates of HMLE and mesHMLE cells was subjected to deep sequencing, using library preparation procedures and bioinformatics pipelines designed to detect circRNAs (refer to Experimental Procedures). We detected 5,178 distinct circRNAs in HMLE and 8,084 circRNAs in mesHMLE cells, of which 3,417 were common to both cell types ( Figure 1C ; Table S1 ). These circRNAs are produced from 3,632 genes, meaning that circRNAs are not pervasive, rather being produced from approximately 22.5% of the transcriptome (16,138 genes with FPKM >0.1) in these cells. To validate the circRNA analysis pipeline, we selected a subset of circRNAs that vary in their abundance, size, and genetic location and performed RT-PCR on RNase R-treated RNA from HMLE and mesHMLE cells using circRNAspecific divergent primers ( Figure 1A ). We successfully amplified the expected product from 75/78 predicted circRNAs (Figure S1 ; Tables S1 and S2), authenticating our circRNA prediction pipeline.
To check that the increase in circRNAs in mesHMLE cells was a consequence of active regulation rather than a consequence of increased transcription of the parent gene, we quantified circRNAs arising from abundant transcripts (FPKM >1.0) that were largely unchanged (< 25% change) in EMT. The relative proportions of these circRNAs in HMLE and mesHMLE cells were similar to circRNAs derived from all transcripts ( Figure 1C ), indicating that substantially more of these circRNAs were present in mesenchymal cells than in epithelial cells. To assess whether there was a tendency for circRNAs that are present in HMLE cells to increase in abundance following EMT, we analyzed all abundant circRNAs common to HMLE and mesHMLE cells and plotted the fold change in circRNA abundance against the fold change in abundance of the cognate mRNA ( Figure 1D ). While the mRNA fold changes exhibited a symmetrical, normal distribution in response to TGF-b treatment, the circRNA profile was positively shifted toward increased abundance ( Figure 1D ). To verify this regulation, we performed quantitative (q)RT-PCR using primers designed to measure several of the strongly regulated circRNAs, which confirmed that the circRNAs from POLE2, OXNAD1, SHPRH, SMAD2, and ATXN2 were all increased over 40-fold by the TGF-b treatment, while circRNAs from DOCK1 and GNB1 were strongly decreased ( Figure 1E ).
To assess whether circRNA formation might be a mechanism to encourage long range exon skipping in the parent transcript, we analyzed the RNA sequencing data for evidence of mRNA isoforms of SMARCA5, POLE2, SHPRH, SMAD2, and ATXN2 in which the circRNA-forming exons are skipped. We found in most samples there were no reads corresponding to this form of exon skipping. Where such exon skipping was detected, it corresponded to <1% of the non-skipped mRNA isoform. Thus, regulated circRNA formation does not appear to be a mechanism for regulating exon skipping.
To check that the increases in circRNAs were not due to a reduced cell proliferation rate following EMT, allowing more accumulation of stable circRNAs, we measured the proliferation rates of the HMLE and mesHMLE cells and found the proliferation rate of mesHMLE cells is actually higher than that of HMLE cells ( Figure S2 ). Thus, the increases in circRNA levels are due to increased biogenesis. Furthermore, given that >62% of circRNAs were cell-type-specific, being detected in only HMLE or mesHMLE cells ( Figure 1C ), despite the similar abundance of their cognate mRNA, this precludes complementary basepairing in introns alone as the mechanism of biogenesis for the majority of circRNAs in these cells. Rather, these results suggest substantial regulation of circRNA biogenesis, independent of changes in abundance of the parental transcript during EMT.
A Focused Screen for Regulators of circRNA Formation
The regulation of circRNA formation during EMT suggests there may be regulatory factors that participate in circRNA biogenesis. We postulated that if a protein factor contributes to circRNA biogenesis, it would also be regulated over the same timecourse. To provide a tool to screen for regulatory factors that affect circRNA formation, we constructed a dual color fluorescent reporter, called circScreen, enabling simultaneous quantification of both linear and circRNA splicing from a minigene reporter construct ( Figure 2A ). The circScreen reporter construct incorporates exons 14-17 of the SMARCA5 gene, a member of the SWI/SNF family of chromatin remodelling proteins, which are as frequently mutated in cancer as p53 (Wang et al., 2014b) , primarily chosen because (1) this region produces an abundant circRNA comprised of exons 15 and 16, the abundance of which was increased 8-fold following EMT ( Figure 1E ) with minimal change in the abundance of the linear mRNA transcript (FPKM HMLE = 23.0, FPKM mesHMLE = 26.9), (2) it lacks complementary Alu elements, and (3) it is comprised of sufficiently small exons and introns to permit a modest-sized reporter plasmid. The reporter was constructed such that the normally untranslated circRNA produced from the minigene undergoes IRESmediated translation of GFP, while the linear mRNA that is produced gives rise to red fluorescing mCherry ( Figure 2A ). Both fluorescent proteins are tagged (GFP-FLAG, mCherry-HA) and have nuclear localization signals inserted, confining them to the nucleus to aid quantitation of cellular fluorescence (analysis pipeline summarized in Figure S3 ). We verified that the reporter was accurately spliced ( Figure S4A ) and gave rise to nuclear green fluorescence that could be almost eliminated by co-transfection of either of two small interfering (si)RNAs targeting the exon16/exon15 junction unique to the circRNA, without significantly affecting mCherry levels ( Figure 2B ), as confirmed by qPCR and western blot ( Figure S4B ). To identify splicing-associated factors involved in circRNA biogenesis, we first selected a candidate panel of nuclear RNA binding proteins (RBPs) (based on Gene Ontology annotations) that were expressed at appreciable levels (>0.1 FPKM in polyA + RNA-sequencing from at least one sample) and were changed in abundance by >2-fold, either up or down, following EMT (Table 1) . We also incorporated siRNAs that target the three human homologs of Drosophila Muscleblind (MBNL1, MBNL2, and MBNL3) implicated in circRNA biogenesis from its cognate locus (Ashwal-Fluss et al., 2014) . We examined the effect of siRNA-mediated knockdown of each of these RBPs on circRNA formation using the circScreen minigene reporter in the readily transfectable HEK293T cell line, which has been shown to be capable of circRNA formation from the SMARCA5 locus (Memczak et al., 2013) . The knockdown of most members of the RBP panel, and all three MBNL homologs, had little effect on the ratio of GFP:mCherry, but knockdown of QKI caused a substantial decrease in the ratio, indicating the QKI protein is required for efficient formation of circRNA from this reporter (Figure 2B) . The decrease in circRNA production on knockdown of QKI was confirmed by western blotting and qRT-PCR, which showed a reduction in tagged GFP reporter protein and in circRNA, but not linear RNA from the transgenic and endogenous genes ( Figures S4C and S4D) . Importantly, we confirmed that QKI protein is increased in the cells that have undergone EMT ( Figure 2C ) and is knocked down by >90% by siRNA-mediated silencing ( Figure S4E ). 
QKI Regulates Formation of circRNAs via Binding Sites in Introns
The effect of QKI on circRNA formation could conceivably be indirect, or could be through direct binding of QKI to the pre-mRNA. To assess whether QKI binds the SMARCA5 pre-mRNA, we performed RNA-immunoprecipitation (RIP) assays ( Figure S5 ), using qRT-PCR to quantify QKI occupancy within the introns adjacent to the circRNA-forming exons. We found that QKI binds to the exon-adjacent sites at a level comparable to its binding to a site in the previously validated QKI target, NUMB (Zong et al., 2014) , whereas binding to more remote regions elsewhere in SMARCA5 and to the circRNA itself was negligible ( Figures 3A and 3B ). To assess whether QKI binding sites in the introns flanking the circRNA-forming exons of SMARCA5 are necessary for circRNA biogenesis, we searched for sequences that match potential QKI response elements in the vicinity of the QKI RIP-enriched regions ( Figures 3A and 3B ) and found four instances of a bipartite motif that contains the sequence UAAY in conjunction with a relaxed version of the canonical QKI hexamer previously determined by SELEX . There are two of the putative elements that are located upstream and two are located downstream of the circRNA-forming splice sites, as shown in Figure 3C . Mutation of any of the putative binding sites individually had little effect on circRNA formation, but mutation of both members of either the upstream pair or the downstream pair substantially reduced circRNA formation, while mutation of all four sites was even more effective ( Figure 3D ). Knockdown of QKI strongly reduced circRNA formation from the intact or singly mutated reporter, but not from the reporter with both members of the pair mutated, confirming the absence of offtarget effects on the reporter ( Figure S4E ). Together, these data indicate that QKI binds upstream and downstream of the circRNA-forming exons in SMARCA5 to promote circRNA formation.
To more broadly assess the role of QKI in circRNA production, we examined the effect of QKI knockdown on the abundance of 13 circRNAs that were previously identified in HEK293T cells (Memczak et al., 2013) and compared this with the presence or absence of known QKI PAR-CLIP sites (Hafner et al., 2010) in the introns flanking the circRNA-forming exons. The abundance of all nine circRNAs with adjacent QKI PAR-CLIP sites was reduced following QKI knockdown, whereas the four that are devoid of adjacent sites were largely unaffected ( Figure 3E ). To extend the identification of QKIdependent circRNAs in the EMT context, we performed RNA sequencing on RNA from two biological replicates of mesHMLE cells in which QKI was knocked down by siRNA treatment and the abundances of the circRNAs were compared with those in control mesHMLE cells. We found that there was a strong bias toward decrease in circRNA abundance ( Figure 3F ). Of the 300 most abundant circRNAs in mesHMLE cells, 105 were decreased more than 2-fold by QKI knockdown, whereas only seven were increased by more than 2-fold ( Figure 3F ). We also confirmed by qRT-PCR that the increase in circRNAs from SMARCA5, POLE2, OXNAD1, SHPRH, SMAD2, and ATXN2 that occurred in EMT ( Figure 1E ) was abrogated by QKI knockdown, while DOCK1 and GNB1, which lack QKI response elements (QREs) in the adjacent introns, were unaffected by QKI knockdown ( Figure S4I ). To investigate which of the three isoforms of QKI is responsible for circRNA formation, we knocked down each isoform individually in mesHMLE cells and measured the levels of the QKI-dependent SMARCA5, POLE2, SHPRH, SMAD2, and ATXN2 circRNAs by qRT-PCR. The isoform-specific siRNAs that target QKI-6 and QKI-7 had little effect on these circRNA levels, whereas the QKI-5-specific siRNA reduced the level of all five circRNAs ( Figures S4F and  S4G ), indicating it is QKI-5 that is responsible for the circRNA formation, consistent with this nuclear isoform acting on circRNA formation during splicing. Consistent with a role for QKI binding in regulating circRNA production in EMT, we found, using the PAR-CLIP data of Hafner et al. (2010) to indicate potential QKI binding sites, that the EMT-regulated circRNAs were 1.3-fold more likely than unregulated circRNAs to have a QKI site in a flanking intron and 2.1 times more likely to have QKI sites in both flanking introns. Together, these data demonstrate that QKI plays a major role in regulating circRNA production during EMT.
To establish that circRNA regulation by QKI is sustained for longer periods, QKI was stably knocked down by two different QKI-specific small hairpin (sh)RNAs in mesHMLE cells, reducing QKI protein by >85% ( Figure 4A ). Compared to a scrambled universal shRNA, the change in abundance of circRNAs measured by qRT-PCR mimicked that for the siRNA ( Figure 4B ). Interestingly, overexpression of QKI in mesHMLE cells ( Figure 4C ) increased the circRNA abundance in two independent clones ( Figure 4D ), revealing a quantitative positive correlation between QKI abundance and circRNA biogenesis. This was confirmed beyond the HMLE EMT model by performing qRT-PCR on four circRNAs (SMARCA5, POLE2, SHPRH, and DOCK1) in the prototypical epithelial (MCF7) and mesenchymal (MDA-MB-231) breast cancer cell lines. The circRNAs from SMARCA5, POLE2, and SHPRH, which are flanked by QKI PAR-CLIP motifs, were more abundant in the mesenchymal cell line, which express over 2.5-fold more QKI transcript than MCF7 cells, while DOCK1 was more abundant in the epithelial cell line ( Figure S6A ). This indicates that the relationship between QKI and circRNA production is maintained in breast cancer cells.
Insertion of Synthetic QKI Binding Sites into Introns Is Sufficient to Generate circRNA Formation
As a conclusive test of QKI-directed circRNA biogenesis, we investigated whether exons that do not normally produce circles could be made competent to produce circRNA by insertion of QKI binding motifs into the adjacent introns. We selected four genes, SYT8, ADD3, TIMP1, and NACAD, that are expressed, but do not give rise to circRNAs in HMLE, mesHMLE, MDA-MB-231, or HEK293T cells. Minigene expression vectors were constructed to express a region encompassing three exons from each of these genes, with and without canonical QKI binding motifs (ACUAACN 1-20 UAAC motif determined by SELEX, see Galarneau and Richard, 2005) inserted in both introns flanking the central exon ( Figure 5A ). The minigenes were expressed in HEK293T cells ( Figure 5 ) and MDA-MB-231 cells ( Figures S6B  and S6C ) and assayed for circRNA formation by RT-PCR using divergent primers that can only give a product from circularized RNA ( Figure 5B) . None of the unmodified minigenes was capable of producing a circRNA, including ADD3, which contains two QKI PAR-CLIP sites 5 0 to the central exon (Hafner et al., 2010) . However, insertion of another intronic QRE downstream of the central exon in ADD3, and insertion of QREs into both flanking introns for the other three reporters resulted in production of circRNA from each minigene ( Figure 5B ), verified by sequencing of the RT-PCR products and by their resistance to treatment with RNase R, an exonuclease that degrades linear, but not circular, RNA (Figure 5B) . To verify that the circRNA production was dependent on QKI, the effect of siRNA-mediated QKI knockdown was tested, and it was found that this largely abrogated circular, but not linear product formation in the RT-PCR ( Figure 5B ), consistent with circRNA production being dependent on QKI. Together, our data show that QKI promotes circRNA production 
DISCUSSION
From deep sequencing of RNA, we have detected thousands of circRNAs present in HMLE epithelial cells and in their mesenchymal counterparts that are formed in response to prolonged exposure to TGF-b. We verified that the sequence analysis pipeline appropriately identifies circRNAs by performing RT-PCR on RNase R-treated RNA, using divergent primers that amplify across the splice junction unique to the circular form of the RNA. Consistent with previous studies on different cell types (Guo et al., 2014; Jeck et al., 2013; Salzman et al., 2013) , we found that the majority of circRNAs in epithelial cells, and in their mesenchymal derivatives, are of low abundance and consequently could conceivably be the result of errors in pre-mRNA splicing, but certain circRNAs were present at substantial levels that suggest they are purposefully produced. Furthermore, the production of numerous abundant circRNAs was regulated in response to TGF-b, independent of changes in their cognate mRNA transcript, which strongly suggests they are produced to carry out some function in these cells. Most of the circRNAs whose level changed substantially in EMT were upregulated, suggesting they carry out functions related to the mesenchymal phenotype. A smaller number were also strongly changed in the opposite direction, consistent with these circRNAs having epithelial-specific functions. For example, the DOCK1 circRNA is one of the most abundant circRNAs in the epithelial cells, but was downregulated 30-fold in response to TGF-b. In light of the observation that circRNA production competes with linear splicing of pre-mRNA (Ashwal-Fluss et al., 2014) , it is interesting to note that the level of DOCK1 mRNA was increased (by about 2-fold) in response to TGF-b, raising the possibility that one function of excision of the DOCK1 circRNA could be to contribute to downregulation of DOCK1 mRNA in epithelial cells. DOCK1 is a guanine nucleotide exchange factor (GEF) that activates Rac to enhance cell motility (Gadea and Blangy, 2014) , consistent with its upregulation in EMT. Nevertheless, because the DOCK1 circRNA is so abundant in epithelial cells, it is tempting to speculate that it has a function in these cells apart from a role in reducing expression of the DOCK1 mRNA.
Our finding of frequent regulation of circRNA abundance in EMT is a strong argument in favor of these circRNAs having functions in the cell, although these functions remain largely unknown. Just two circRNAs have had functions ascribed to them to date: ciRS-7/CDR1as acts as a sponge for miR-7 in mammalian cells, and a circRNA from the testes-specific Sry gene acts as a sponge for miR-138 (Capel et al., 1993; Hansen et al., 2013; Memczak et al., 2013) . We searched for reiterated miRNA binding sites in the circRNAs that are regulated by TGF-b treatment of HMLE cells, but did not find any notable examples, suggesting they do not act as miR sponges. This observation is in agreement with the report of Guo et al. (2014) that the majority of circRNAs appear to not function as miRNA sponges.
We observed that changes in circRNA levels were mostly in the direction of increased abundance in the mesenchymal cells, but at least for the more abundant circRNAs, their expression was not exclusively mesenchymal. Several abundant circRNAs were identified to change by 4-10-fold, while about 50 changed by 2-4-fold, with many of these having substantial abundance in the epithelial cells (Table S1 ). This contrasts with the almost exclusively mesenchymal expression of key transcription factors (such as ZEB1, Twist1, and Snail) that drive the mesenchymal gene expression program and suggests that the functions of the upregulated circRNAs are not likely to be exclusive to mesenchymal cells. More relevant comparisons in this regard may be to genes that are expressed in epithelial cells, but are increased in mesenchymal cells because they participate in activities such as controlling cell shape, ECM interactions, or migration, which are more prominent in the mesenchymal phenotype. For example, some tubulin, cofilin, and laminin transcripts have these features and were moderately increased in EMT.
Because circRNAs are likely to be quite stable, it is tempting to speculate that the functions of some circRNAs may take advantage of their long half-lives, allowing them to act as slow-responding regulators. A long half-life confers a slow approach to steady-state level and a slow decline if their production ceases. Furthermore, if the degradation rate is considerably longer than the rate of cell division, the steady-state level becomes sensitive to the cell division rate, which effectively replaces degradation in determining the abundance of the circRNA. EMT is a rather special type of induced cellular response in that it causes a profound change in the differentiation state of the cell, but at least in vitro, is readily reversible in the initial days of induction, and then becomes more refractory to reversion, but nevertheless remains reversible (Gregory et al., 2011) . This has parallels in vivo as exemplified by the reversals of EMT that occur in some tissues during embryological development, while reversible plasticity is thought to play an important role in metastatic colonization (Brabletz, 2012; Nieto, 2013) . Perhaps some circRNAs that are induced during EMT could be involved in helping to determine the slow development, or the duration, of a refractory mesenchymal state.
We have found that a substantial contribution to the regulation of circRNA production in EMT comes from the regulation of circularization by the mesenchymal splicing factor, QKI. QKI is essential for enhanced production of many circRNAs and acts by binding to recognition elements within introns, in the vicinity of the circRNA-forming splice sites. Furthermore, insertion of QKI motifs is sufficient to induce circRNA formation in contexts where this is normally not observed. Secondary structure within pre-mRNAs that brings circRNA-forming exons into close proximity has been shown to enhance circRNA biogenesis (Liang and Wilusz, 2014; Zhang et al., 2014) . Since QKI is a dimer, capable of binding two well separated regions of a single RNA molecule (Teplova et al., 2013) , it is an attractive possibility that QKI likewise promotes circRNA biogenesis by bringing the circle-forming exons into close proximity.
Our observations that QKI levels are regulated in the EMT produced by TGF-b treatment of HMLE cells, and that QKI-regulated circRNAs similarly change in abundance, suggest that circRNAs could have important functions in EMT. Since EMT is widely regarded to have an important role in the progression of carcinomas to metastasis (Scheel and Weinberg, 2012; Tsai and Yang, 2013) it will be interesting to examine the influence of QKI-mediated circRNAs in cancers.
EXPERIMENTAL PROCEDURES Cell Lines and Cell Culture
Human HMLE cell line cells were cultured and induced to undergo EMT as per Mani et al. (2008) using 2 ng/ml À1 TGF-b1 (Sigma-Aldrich). HEK293T, MCF-7, and MDA-MB-231 immortalized breast cancer cells were maintained in Dulbecco's modified Eagle's medium (DMEM) GlutaMax (Life Technologies) with 10% (volume per volume) heat-inactivated fetal calf serum (Bovogen) and 13 Penicillin-Streptomycin (Gibco) at 37 C with 5% CO 2 .
qRT-PCR Reverse transcription for mRNA and circRNAs were performed with SuperScript III First-Strand Synthesis System (Life Technologies) and 50 ng random hexamers or 2.5 mM oligo (dT) 20 as per manufacturers instructions. miRNA qRT-PCR was performed with TaqMan assay as per Gregory et al. (2008) . RT-PCR was subsequently performed in triplicate with a 1:10 dilution of cDNA with 13 iQ SYBR Supermix (QIAGEN) on a Rotorgene 6000 series PCR machine (Corbett Research). Analysis was performed as per Gregory et al. (2008) . Bioinformatics Raw reads were adaptor trimmed and filtered for short sequences using cutadapt v1.3 (Martin, 2011) , using minimum-length 18, error-rate 0.2, overlap five, paired-output options. The resulting FASTQ files were analyzed and quality checked using the FastQC program (http://www.bioinformatics.babraham. ac.uk/projects/fastqc). The remaining reads were mapped against the GRChr37/hg19 human reference genome using the MapSplice spliced alignment algorithm (Wang et al., 2010) (version 2.1.8 beta, using parameters -bam -fusion -fusion-non-canonical -filtering 1 -min_fusion_distance 200-gene-gtf Ensembl). The number of reads supporting each circRNA junction was obtained from the resulting splice junction files. Normalization was performed using a set of 165 linear non-polyadenylated ''housekeeping'' transcripts judged to be ubiquitously and consistently expressed across samples. This set included 39 small nucleolar RNA, 32 processed pseudogenes, 18 sense intronic elements, 18 snRNAs, eight large intergenic non-coding RNAs, and six miRNAs. Specifically, after taking logarithms, additive normalization factors were determined such that after normalization the sample-averaged expression of the housekeeping RNAs was identical to the overall expression average. These sample-specific normalization factors were then used to calculate appropriately normalized circRNA counts for each sample. As a cross-check of the normalization procedure we used, for a subset of the samples, a spike-in of a synthetic circRNA (refer to Extended Experimental Procedures for in vitro transcription of circRNAs). We found that, as expected, the normalization procedure tended to result in equilibrated spike-in levels.
Library Preparation
circScreen Reporter Construct The genomic region of SMARCA5 was directionally cloned into pcDNA3.1 from HEK293T genomic DNA using primers SMARACA5_BamHI_F and SMARACA5_NotI_R (all DNA oligonucleotides in Table S1 ) with Phusion Hot Start Polymerase (Thermo Fisher Scientific) according to manufacturer's instructions. Cytomegalovirus internal ribosomal entry site (CMV-IRES) was amplified from pLMP-Cherry and cloned into the BstBI site of SMARCA5 Exon 16. GFP was amplified from pDendra2 vector (Clontech) to include N-terminal nuclear localization signal (NLS and KKKRKV) and C-terminal FLAG tag (DYKDDDK) and cloned into the BsaBI site of SMARCA5 Exon 15. NLSmCherry-HA was generated from two overlapping gBlocks gene fragments (Integrated DNA Technologies) into PflFI sites, inserting mCherry into Exon 17 to complete the circScreen reporter. Mutation of QREs and deletion of inverted repeats from the circScreen reporter were achieved with DpnI-based (New England Biolabs) site-directed mutagenesis with Phusion DNA Polymerase. Sanger sequencing and restriction digestions confirmed sequence/frame and orientation of fragments.
Nuclear RBP siRNA Screen Cells were transfected with siRNAs at 5-20 nanomolar (nM) final concentration using Lipofectamine RNAiMAX (Life Technologies) in 24-well plates, while expression plasmids (1 mg) were transfected with Lipofectamine 2000 (Life Technologies). For the circScreen reporter assay, siRNAs were transfected into HEK293T cells 40 hr prior to transfection with the circScreen plasmid. At five hours after circScreen transfection, the culture media was changed to 1:3 DMEM:F-12 (Life Technologies) with 10% heat-inactivated fetal calf serum and 13 Penicillin-Streptomycin to reduce green autofluorescence. Cells were imaged on the IncuCyte Zoom (Essen Bioscience) capturing phase, green, and red fluorescence images at 103 magnification over the next 48 hr (refer to Figure S3 for detailed image analysis).
Incorporation of QREs into Minigene Reporters
There was four genes-SYT8, TIMP1, NACAD, and ADD3-that were chosen, as they were devoid of any circRNAs. Genomic regions comprising three exons and two introns were synthesized (Integrated DNA Technologies) with and without consensus QREs (ACUAAC(N 17 )UAAC) approximately 100-200 bp from the splicing site of the central exon. These were cloned into pcDNA3.1 and transfected into HEK293T cells that had been transfected 40 hr previous with negative control siRNA or QKI ON-Targetplus SMART pool siRNA (Dharmacon). RNA was isolated 24 hr later with TRIzol and treated with Ribonuclease R (RNase R, Epicenter) as per Jeck et al. (2013) , cDNA was reverse transcribed using random hexamers and SuperScript III reverse transcriptase (Life Technologies).
RNA Immunoprecipitation
MDA-MB-231 cells were UV cross-linked at 600 mJ/cm À2 and lysed in 13 PXL lysis buffer (13 PBS, 0.1% SDS, 0.5% sodium deoxycholate, and 0.5% NP-40 with 13 Protease Inhibitor Cocktail [Promega]). Lysate was treated with DNase I (Roche) at 37 C for 10 min and centrifuged at 12,000 g for 30 min. Total protein (1 mg) was indirectly immunoprecipitated with 5 mg of a-QKI-5 rabbit polyclonal antibody (Bethyl Laboratories, A300-183A), or rabbit anti-mouse IgG antibody (Jackson Laboratories) as a control, and 100 ml of Protein G magnetic dynabeads (Life Technologies). Beads were washed twice with 13 PXL lysis buffer, followed by two washes each with 53 PXL and 13 PNK buffer (50 mM Tris-Cl [pH7.5], 10 mM MgCl 2 , and 0.5% NP-40). There was thirty percent of the immunoprecipitate that was set aside for western blot analysis, with protein eluted from beads in 13 PNK buffer, 43 LDS Loading Buffer (Life Technologies) and 4% b-mercaptoethanol at 70 C for 10 min. There was twenty percent of the immunoprecipitate that was treated for 20 min at 37 C with a Proteinase K solution (4 mg/ml Proteinase K in 100 mM Tris-Cl [pH 7.5], 50 mM NaCl, and 10 mM EDTA). An equal volume of Proteinase K solution including 7 M urea was then added and incubated at 37 C for a further 20 min, after which the RNA was extracted using phenol:chloroform. Samples were spun at 12,000 g, at 4 C for 10 min. The aqueous phase was collected and RNA precipitated overnight with 3 M sodium acetate [pH5.2], 20 mg glycogen, and 1:1 ethanol:isopropanol. The RNA pellet was washed twice with 75% ethanol, air-dried, and resuspended in water.
Establishment of Cell Lines Stably Overexpressing QKI cDNA Human QKI-5 cDNA was PCR amplified from pENTR-QKI (Addgene plasmid #16183) to include a stop codon and cloned into the BamHI and NotI sites of the pENTR2B entry vector (Invitrogen). The resulting pENTR2B-QKI-5 vector was recombined with pLX301 (Addgene plasmid #25895) using LR Clonase to generate pLX301-QKI-5. An expression vector containing mCherry (pLX301-mCherry) was generated by recombination of pENTR2B-mCherry with pLX301. Lentiviral particles were produced from pLX301-mCherry and QKI-5 constructs by co-transfecting HEK293T cells with pCMV5-VSVG and pCMV-dR8.2. A 1:8 dilution of virus was added to mesHMLE cells plated at low density for 96 hr before selection with 1 mg/ml puromycin. Single clones that overexpressed QKI-5 and a control mCherry clonal pool were used for downstream experiments.
Establishment of Cell Lines Stably Overexpressing QKI shRNA Lentiviral vectors for shRNA mediated knockdown of QKI were purchased from Sigma-Aldrich (Mission pLKO; TRCN0000233372 and TRCN0000 233375) along with a non-targeting control shRNA (Mission SHC216). Lentiviral particles and selection of stable mesHMLE pools were carried out as described above for the pLX301 vectors.
Western Blotting
Western blotting was performed according to standard protocols and imaged using the Odyssey CLx scanner (LI-COR). Primary antibodies used in this study were as follows: anti a-tubulin mouse monoclonal (Abcam, ab7291, 1:10,000), anti-FLAG mouse monoclonal (Sigma, F1804, 1:4,000), anti-HA mouse monoclonal (Sigma, H3663, 1:1,000), anti-QKI5 rabbit polyclonal (Bethyl Laboratories, A300-183A, 1:5,000), and anti-E-cadherin mouse monoclonal (BD Biosciences, 610182, 1:1,000). Secondary antibodies used were, Goat anti-mouse IRDye680 (LI-COR, 926-32220, 1:20,000), Goat anti-rabbit IRDye680 (LI-COR, 926-32221, 1:20,000), Goat anti-mouse IRDye800 (LI-COR, 926-32210, 1:20,000); Goat anti-rabbit IRDye800 (LI-COR, 926-32211, 1:20,000).
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